Capricor Therapeutics | CAPR - Dochód Netto





Dochód Netto Zmiana Data
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Bioline Rx USD -3.03M 1.42M 2026-06
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 8.78B 884.9M 2026-09
Cytokinetics USD -190.07M 8.69M 2026-09
Geron USD 1.35M 18.03M 2026-09
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -19.3M 6.28M 2025-12
J&J USD 210M 5.32B 2026-09
Plus Therapeutics USD -6.95M 1.23M 2026-03
Prothena USD -18.58M 51.3M 2026-06
PTC Therapeutics USD 83.5M 86.3M 2026-06
Sarepta Therapeutics USD -28.46M 23.57M 2026-09